Closed
1.8 -1.85
24h
Min
1.7
Max
1.856
Income | -25M |
---|---|
Sales | 12M |
Profit margin | -200.599 |
Employees | 181 |
EBITDA | -26M |
Recommendations | Buy |
---|---|
12 Months Forecast | +137.75% upside |
Market Cap | 159M |
---|---|
Previous open | 3.65 |
Previous close | 1.8 |
By Trading Central
Confidence
Weak Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 4.398 EUR 137.75%
High 5.7 EUR
Low 3.1 EUR
Based on 2 Wall Street analysts offering 12 month price targets forInnate Pharma SA - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$